The combined results indicated that elevated GHET1 expression levels were significantly correlated with poor OS (HR = 2.40, 95% CI: 1.87–3.08, p < 0.001) and tumor progression in multiple cancers (III/IV vs. I/II: HR = 1.80, 95% CI: 1.48–2.18, p < 0.001) (Figures 2(a) and 2(b)). Here, GHET1 is linked to neoplasm.